Literature DB >> 9764812

Multiple primary melanomas: analysis of 49 cases.

P Savoia1, P Quaglino, A Verrone, M G Bernengo.   

Abstract

Development of multiple primary melanomas is a rare but well recognized disease, with an estimated incidence ranging from 1.75% to 8.5% in several series. The clinical, histological and epidemiological characteristics of 49 patients, identified from 2470 with histologically confirmed melanoma, are described in this study. Thirty-five of these patients had two primary melanomas, 11 had three melanomas and three had four, five and six melanomas, respectively. Diagnosis was concurrent in 22 patients (45%); in the remaining cases the median time interval between the first and second melanoma was 22.6 months and the longest interval was 21.5 years. The mean Breslow's thickness decreased significantly (P < 0.001) from the first melanoma to the second and third lesion. The multiple melanoma patients had a higher percentage of subjects over 70 years of age or with lentigo maligna melanoma than single melanoma patients. The mean follow-up time was 12 years (range 4 23 years). The 5-year survival rate from first melanoma excision (83%) does not differ from that of patients with a single melanoma. In conclusion, the presence of multiple primary melanomas does not appear to be a negative prognostic factor; our data show the importance of close follow-up in melanoma patients in order to detect not only metastases, but also subsequent primaries in their earliest phases.

Entities:  

Mesh:

Year:  1998        PMID: 9764812     DOI: 10.1097/00008390-199808000-00010

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  8 in total

1.  Increased risk of second primary cancers after a diagnosis of melanoma.

Authors:  Porcia T Bradford; D Michal Freedman; Alisa M Goldstein; Margaret A Tucker
Journal:  Arch Dermatol       Date:  2010-03

2.  Separate Primary Melanomas of the Bulbar Conjunctiva and Eyelid Skin: Clinical Implications of Multiple Primary Melanomas.

Authors:  Frances A Jacinto; George H Fisher; Edgar M Espana; Ilya M Leyngold; Curtis E Margo
Journal:  Ocul Oncol Pathol       Date:  2016-04-21

3.  Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.

Authors:  Rajmohan Murali; Chris Goumas; Anne Kricker; Lynn From; Klaus J Busam; Colin B Begg; Terence Dwyer; Stephen B Gruber; Peter A Kanetsky; Irene Orlow; Stefano Rosso; Nancy E Thomas; Marianne Berwick; Richard A Scolyer; Bruce K Armstrong
Journal:  Ann Surg Oncol       Date:  2011-09-13       Impact factor: 5.344

4.  Nevi, family history, and fair skin increase the risk of second primary melanoma.

Authors:  Victor Siskind; Maria Celia B Hughes; Jane M Palmer; Judith M Symmons; Joanne F Aitken; Nicholas G Martin; Nicholas K Hayward; David C Whiteman
Journal:  J Invest Dermatol       Date:  2010-10-14       Impact factor: 8.551

5.  Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients.

Authors:  Haike M J van der Velden; Michelle M van Rossum; Willeke A M Blokx; Jan B M Boezeman; Marie-Jeanne P Gerritsen
Journal:  Dermatol Res Pract       Date:  2009-12-31

6.  Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.

Authors:  Anne Kricker; Bruce K Armstrong; Chris Goumas; Nancy E Thomas; Lynn From; Klaus Busam; Peter A Kanetsky; Richard P Gallagher; Loraine D Marrett; Pamela A Groben; Stephen B Gruber; Hoda Anton-Culver; Stefano Rosso; Terence Dwyer; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2013-08       Impact factor: 10.282

7.  Double Primary Acral Lentiginous Melanoma of both Soles.

Authors:  Jae Ho Lee; Youngkyung Lim; You Jin Lee; Ji-Hye Park; Dong-Youn Lee
Journal:  Ann Dermatol       Date:  2017-02-03       Impact factor: 1.444

8.  Multiple Primary Cutaneous Melanomas in a Bulgarian Patient: The Possible Role of One Step Melanoma Surgery (OSMS) As the Most Adequate Treatment Approach!

Authors:  Georgi Tchernev; Ivanka Temelkova
Journal:  Open Access Maced J Med Sci       Date:  2018-11-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.